Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 8Sarcoma 3Gynecologic 3Genitourinary 3Gastrointestinal 3Other hematologic neoplasm 2Lymphoid 2CNS 2Thoracic 1Plasma cell 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 264Leukemia, Lymphocytic, Chronic, B-Cell 249Leukemia, Myeloid, Acute 236Leukemia 235Lymphoma 177Lymphoma, Non-Hodgkin 168Lymphoma, Follicular 154Burkitt Lymphoma 146Lymphoma, Large B-Cell, Diffuse 142Lymphoma, B-Cell, Marginal Zone 135Lymphoma, Mantle-Cell 133Lymphoma, Large-Cell, Immunoblastic 115Hodgkin Disease 109Myelodysplastic Syndromes 107Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 96Congenital Abnormalities 90Multiple Myeloma 86Lymphoma, T-Cell, Cutaneous 81Lymphoma, Large-Cell, Anaplastic 76Hematologic Neoplasms 75Leukemia, Myelomonocytic, Chronic 74Waldenstrom Macroglobulinemia 73Immunoblastic Lymphadenopathy 70Leukemia, Myelomonocytic, Acute 69Sezary Syndrome 68Mycosis Fungoides 68Blast Crisis 68Leukemia, Monocytic, Acute 62Myeloproliferative Disorders 61Leukemia, Myelogenous, Chronic, BCR-ABL Positive 61

Interventions

Radiotherapy 1Pentetic Acid 1Ifosfamide 1Filgrastim 1Fibroblast Growth Factor 7 1Etoposide 1Daclizumab 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Radiation Injuries × Other hematologic neoplasm × Clear all
NCT00004132 2013-06-26

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

National Cancer Institute (NCI)

Phase 2 Completed
LymphoidOther hematologic neoplasmPlasma cellSarcoma

Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Radiation Injuries, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Drug-Related Side Effects and Adverse Reactions

NCT00019227 2013-06-20

Monoclonal Antibody Therapy in Treating Patients With Leukemia

National Cancer Institute (NCI)

Phase 1/2 Completed
LymphoidOther hematologic neoplasm

Lymphoma, Radiation Injuries, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡